Abbott Receives FDA Approval for Aveir™ VR Leadless Pacemaker System to Treat Patients with Slow Heart RhythmsPRNewsWire • 04/04/22
Abbott and LISC Team Up to Address Diversity and Equity Gaps in the Healthcare Industry Supply ChainPRNewsWire • 03/30/22
Investing Club: We don't need two stocks tied to Covid diagnostics, so we exited one of themCNBC • 03/28/22
Abbott's FreeStyle® Libre is First and Only CGM System to Gain Expanded Reimbursement in Japan to Include All People with Diabetes Who Use InsulinPRNewsWire • 03/24/22
Abbott (ABT) Down 1.4% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 02/25/22
Abbott's CardioMEMS™ HF System Receives FDA Approval to Support Patients Battling Earlier-Stage Heart FailurePRNewsWire • 02/21/22